Cited by 32Vestibular and auditory disordersInflammatory Biomarkers in Disease PrognosisHearing, Cochlea, Tinnitus, Genetics

Predictive value of neutrophil to lymphocyte ratio in first-time and recurrent idiopathic sudden sensorineural hearing loss

Seo, Young Joon, Park, Yoon Ah, Bong, Jeong Pyo, Park, Dong-Joon, Park, Sang Yoo·2015·Auris Nasus Larynx

Abstract

Objective To determine if the neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) in patients with recurrent idiopathic sudden sensorineural hearing loss (ISSNHL) differ from those in healthy people and non-recurrent ISSNHL patients. Methods A retrospective review of 16 patients with recurrent ISSNHL was performed with strict exclusion criteria. Independent variables were NLR and PLR, which yielded four groups (control, non-recurrent, recurrent-first attack, and recurrent-second attack groups). Results Compared with the control group, non-recurrent and recurrent attack groups showed significantly higher NLR values (p Conclusion Evidence of increased NLR and PLR is shown in recurrent ISSNHL and non-recurrent ISSNHL, and these increased levels are shown in the second attack of recurrent ISSNHL. Clinicians are advised to monitor the NLR and PLR at the clinic to predict recurrent ISSNHL even after hearing is restored.

Integrity signals

Registry

Crossref · 10.1016/j.anl.2015.04.011

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Seo et al. reported increased neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in patients with recurrent SSNHL compared to controls.

    “Seo et al. reported increased neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in patients with recurrent SSNHL compared to controls. 9”
  • Four studies reported the improvement rate in patients with their first episode of SSNHL to be 58%-79%.

    “Four studies 6,8 -10 reported the improvement rate in patients with their first episode of SSNHL to be 58% -79%.”
  • The improvement rate of the recurrent SSNHL episode ranged from 21% to 86% across five studies.

    “As for the improvement rate of the recurrent SSNHL episode, five studies, 8,9,11 -13 from 21% to 86%.”
  • Both NLR and PLR were found to be higher in patients experiencing both the first and recurrent episodes of ISSNHL than in a normal control group.

    “Both the neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were found to be higher in patients experiencing both the first and recurrent episodes of ISSNHL than in a normal control group [9].”

Cited by

Sorted by citations

Authors
Seo, Y. J., Park, Y. A., Bong, J. P., Park, D.-J., & Park, S. Y.
Affiliations
Yonsei University (KR)
Corresponding author
Park, Sang Yoo
Venue
Auris Nasus Larynx
Publisher
Elsevier BV
Published
2015-12
Volume
42
Issue
6
Pages
438-442
ISSN
0385-8146 (ISSN-L)
OpenAlex
W1592623817
Cited by
32
References
0
Citations by year
2026: 1 · 2025: 2 · 2023: 2 · 2022: 6 · 2021: 7 · 2020: 1 · 2019: 6 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 1
FWCI
1.24
Type
journal article
Language
en
Open access
closed
Locations
  • Auris Nasus Larynx (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Neurology › Vestibular and auditory disorders
  • Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
  • Life Sciences › Neuroscience › Sensory Systems › Hearing, Cochlea, Tinnitus, Genetics
Keywords
neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, idiopathic sudden sensorineural hearing loss, inflammatory markers, risk prediction, hearing restoration
MeSH terms
Adult, Blood Platelets, Hearing Loss, Sudden, Female, Hearing Loss, Sensorineural, Humans, Lymphocytes, Male, Middle Aged, Neutrophils, Platelet Count, Predictive Value of Tests, Recurrence, Retrospective Studies, Cohort Studies, Odds Ratio, Lymphocyte Count

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review